GMAB
Genmab A/SHealthcare$27.50
▼ Bearish
Mkt Cap: $16.98B|Float: 60.9M|SI: 14.6%|DTC: 4.9
Data as of market close Apr 2, 2026
IV Rank
52
IV Pctl
44%
HV 20d
27.8%
52W Range
$17-$35
ATR(14)
$0.65
Exp. Move
±12.7%
P/C Ratio
1.04
Earnings
May 7
GEX Negative
DEX Long
Net Put Premium
IV Moderate
Max Pain Above
Exp. Move Wide
GMAB Key Options Data
- IV Rank
- 52.2%
- Total GEX
- $-0.00B
- Total DEX
- $0.6M
- Max Pain
- $30.00
- Expected Move
- ±12.7%
- Put/Call OI
- 1.04
- Net Premium
- $-0.5M
- Spot Price
- $27.50
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$3.50 | ±12.7% | $24.00 | $31.00 |
| 2026-05-15 | 43 | ±$4.60 | ±16.7% | $22.90 | $32.10 |
| 2026-08-21 | 141 | ±$7.15 | ±26.0% | $20.35 | $34.65 |
| 2026-11-20 | 232 | ±$6.25 | ±22.7% | $21.25 | $33.75 |
Explore GMAB options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.